|
Transplantation
Citations 311-320 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells
- Ezra Aksoy, Valentina Albarani, Muriel Nguyen, Jean-Francois Laes, Jean-Louis Ruelle, Dominique De Wit, Fabienne Willems, Michel Goldman, and Stanislas Goriely
Blood 2007; 109: 2887-2893.
[Abstract]
[Full text]
[PDF]
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation
- Corey Cutler, Shuli Li, Vincent T. Ho, John Koreth, Edwin Alyea, Robert J. Soiffer, and Joseph H. Antin
Blood 2007; 109: 3108-3114.
[Abstract]
[Full text]
[PDF]
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse
- Benny J. Chen, Divino Deoliveira, Xiuyu Cui, Ngocdiep T. Le, Jessica Son, John F. Whitesides, and Nelson J. Chao
Blood 2007; 109: 3115-3123.
[Abstract]
[Full text]
[PDF]
Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation
- Roland Meisel, Lisa Kuypers, Uta Dirksen, Ralf Schubert, Bernd Gruhn, Gabriele Strauss, Karin Beutel, Andreas H. Groll, Ulrich Duffner, Renate Blütters-Sawatzki, Wolfgang Holter, Tobias Feuchtinger, Hans-Peter Grüttner, Horst Schroten, Stefan Zielen, Christian Ohmann, Hans-Jürgen Laws, and Dagmar Dilloo, for the Impfung von Kindern nach allogener Stammzelltransplantation (IKAST) Study Group
Blood 2007; 109: 2322-2326.
[Abstract]
[Full text]
[PDF]
Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used
- Yvonne Loh, Yu Oyama, Laisvyde Statkute, Kathleen Quigley, Kimberly Yaung, Elizabeth Gonda, Walter Barr, Borko Jovanovic, Robert Craig, Dusan Stefoski, Bruce Cohen, and Richard K. Burt
Blood 2007; 109: 2643-2548.
[Abstract]
[Full text]
[PDF]
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
- Vu H. Nguyen, Robert Zeiser, Daniel L. daSilva, Daisy S. Chang, Andreas Beilhack, Christopher H. Contag, and Robert S. Negrin
Blood 2007; 109: 2649-2656.
[Abstract]
[Full text]
[PDF]
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease
- Margaret L. MacMillan, Daniel Couriel, Daniel J. Weisdorf, Gisela Schwab, Nancy Havrilla, Thomas R. Fleming, Saling Huang, Lorin Roskos, Shimon Slavin, Richard K. Shadduck, John DiPersio, Mary Territo, Steve Pavletic, Charles Linker, Helen E. Heslop, H. Joachim Deeg, and Bruce R. Blazar
Blood 2007; 109: 2657-2662.
[Abstract]
[Full text]
[PDF]
Donor-derived cells and human graft-versus-host disease of the skin
- Hideyuki Murata, Anne Janin, Christophe Leboeuf, Jean Soulier, Eliane Gluckman, Veronique Meignin, and Gerard Socie
Blood 2007; 109: 2663-2665.
[Abstract]
[Full text]
[PDF]
Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells
- Sinead Forde, Britt Jorgensen Tye, Sarah E. Newey, Maria Roubelakis, Jon Smythe, Colin P. McGuckin, Ruth Pettengell, and Suzanne M. Watt
Blood 2007; 109: 1825-1833.
[Abstract]
[Full text]
[PDF]
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis
- Roberto Bellucci, Sabine Oertelt, Meagan Gallagher, Sigui Li, Emmanuel Zorn, Edie Weller, Fabrice Porcheray, Edwin P. Alyea, Robert J. Soiffer, Nikhil C. Munshi, M. Eric Gershwin, and Jerome Ritz
Blood 2007; 109: 2001-2007.
[Abstract]
[Full text]
[PDF]
|
|
